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Abstract
The Italian Institute for Environmental Protection and Research defines national priority 
contaminated sites (NPCSs) as land where hazardous substances are likely to pose a risk 
to human health. SENTIERI was the first national project evaluating the health status of 
residents in NPCSs. We have extended, for the site of Sesto San Giovanni, the evaluation 
to cancer incidence and congenital anomalies (CAs). We have found an overall signifi-
cant negative association between living in the NPCS and overall cancer incidence in all 
ages and no association in paediatric, adolescent and young adults’ population. We have 
found an excess risk for bladder cancer, leukaemia, lymphoid leukaemia and chronic lym-
phocytic leukaemia in men and for lung and breast cancer in women. For the paediatric 
and adolescent population, we have found an excess in embryonic tumours. Total CAs 
were not different from expected, while we have found excesses regarding ear, face and 
neck, digestive system and chromosomal defects.
INTRODUCTION
The health impact of contaminated sites on residents 
is a hot topic worldwide, especially in terms of public 
health decision making, as previous and existing envi-
ronmental stressors can cause local and diffuse accu-
mulation of adverse health conditions, including devel-
opment of cancer and congenital malformations [1, 2]. 
Several countries have established projects to monitor 
contaminated sites [3]. In Italy, the Italian Institute for 
Environmental Protection and Research (ISPRA) has 
identified, in 2010, 57 national priority contaminated 
sites (NPCSs) reduced to 39 in 2013 for administra-
tive reasons, where soil or groundwater contamination 
may impact on human health [4]. They are located in 
every Italian region and cover 1300 km2 of aquatic en-
vironments (marine and lagoon) and 1600 km2 of land 
surface. Each NPCS shows different environmental 
sources depending on its active or dismissed type of in-
dustrial area, landfills or incinerator. 
Several approaches have been implemented for assess-
ing the impact of NPCSs on human health [5]: defining 
the health profile of populations living in NPCSs [6-8]
analysing the associations between environmental expo-
sures and health outcomes [9] and surveillance of the 
evolving pattern of the population health profile [10]. 
The SENTIERI [11, 12] project (Epidemiological Study 
of Residents in National Priority Contaminated Sites) 
was the first national project studying the health profile 
of residents in NPCSs. For each site, overall and cause-
specific mortality has been evaluated between 1995 and 
2002, and excess mortality has been estimated compar-
ing deaths among residents in a NPCS vs mortality expe-
rienced by the corresponding regional population. Over-
all, the observed mortality has exceeded the expected 
rate for all causes and for causes of death with a priori 
sufficient or limited evidence of association with the en-
vironmental exposure, especially in NPCSs located in 
Southern and Central Italy. In 2014, the analyses were 
extended to cancer incidence and hospital discharges 
[13] and in 2019 to congenital anomalies [14]. 
The NPC site of Sesto San Giovanni includes two 
municipalities, Sesto San Giovanni and Cologno 
Monzese, located in the administrative area covered 
by the Health Protection Agency of the Metropolitan 
City of Milan (ATS), the largest metropolitan popula-
tion of Northen Italy. The site, which includes 122 300 
inhabitants, was established by national regulations in 
2000 as having two environmental sources, landfill and 
steel industry. The steel activity of the Falck group be-
gan in 1906 on an area previously used for agriculture 
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with the production of steel and cast iron by fusion. In 
the years 1917-1933 the production of sheets, welded 
tubes and steel wire were implemented. The global cri-
sis of steelmaking in 1971 determined the progressive 
decline and in 1995, the activities of the Falk steelworks 
closed definitively. In 1996, all the steel plants of Sesto 
San Giovanni were dismantled and the first processes 
of redevelopment of disused production areas began. 
The investigations carried out following the reclama-
tion processes started in the 2000s, showed an envi-
ronmental contamination of the soil and subsoil due to 
metal pollution and different organic compounds and 
the overcoming of the normative values in the aqui-
fer for metals, hydrocarbons and organo-chlorinated 
compounds attributable to the site. The site has been 
classified by SENTIERI [12] as having a sufficient or 
limited level of evidence but not sufficient to establish a 
causal association with respiratory diseases and asthma. 
In the literature, a limited evidence of association has 
been demonstrated between hazardous waste related 
exposures and liver, breast, testis and bladder cancers, 
non-Hodgkin lymphoma, asthma and finally between 
landfill and congenital anomalies [8, 15, 16]. On the 
other hand, the relationship between landfill and mal-
formation in the literature is widely investigated with 
a recurrent increased risk of congenital abnormalities, 
albeit not always statistically significant [17]. Breugel-
mans et al. [18] found that the SIR for lung cancer was 
40% higher than average in postcode areas closer to in-
dustrial terrain of a steel plant while Bhopal [19] found 
no evidence to support the hypothesis that living close 
to these major industries led to adverse birth outcomes.
The aim of the present study is to extend, using the 
SENTIERI approach, the health profile of the residents 
in the NPCS of Sesto San Giovanni to the evaluation 
of cancer incidence and malformations, not present in 
the recently published analysis [14] due to the lack of 
data avaible from the two registers at the time of data 
collection. 
MATERIALS AND METHODS
This study considers two health outcomes, cancer in-
cidence and congenital anomalies prevalence, and com-
pares residents in the site of Sesto San Giovanni with 
non-residents. Here we use routinely collected health 
data from the Cancer Registry of the ATS of Milan, 
accredited from 2016 to the International Agency for 
Research on Cancer (IARC), and from the Registry of 
Congenital anomalies (CAs) accredited from 2019 as 
full member to the European Association on Surveil-
lance on Congenital Anomalies (EUROCAT) which 
cover the whole area of the ATS of Milan including the 
area of Sesto San Giovanni. The Registry of CAs in-
cludes live birth, stillbirth and Termination of Pregnancy 
for Anomalies (TOPFA), as required by EUROCAT. 
The population roster, hospital discharge records, birth 
certificate, death certificates and pathology reports are 
included in the registry’s information system. The reg-
istration methods consist in a two steps process: firstly 
through identification of potential malformed subjects 
by using electronic editing, visual editing of the medi-
co-administrative and pathology records and secondly 
through the consultation of medical records by registry 
investigators. Consultation of all medical records allows 
us to have as much data as possible with high quality and 
completeness.
Cancer incidence
The data on cancer incidence from 2007 to 2013 was 
selected from the Cancer Registry of the ATS of Milan, 
nationally accredited to the Italian Association on Can-
cer Registry (AIRTUM) and to the International Asso-
ciation of Cancer Registries (IACR). The investigated 
cancer sites, according to the ICD-10 classification [20], 
includes all cancers (excluding skin) and 35 specific 
sites [14]. Excess cases have been evaluated with Stan-
dardised Incidence Ratios (SIR) stratified by sex, which 
compares the number of observed cases with the number 
of expected cases if they had the same incidence rate of a 
standard population. For each cancer site, the expected 
cases have been calculated from the age and sex specific 
rates of the Italian North-West population between 2006 
and 2010, available from the database of AIRTUM [21] 
between 2006 and 2010, excluding individuals resident 
in a municipality belonging to a NPCS.  
Special attention has been given to the paediatric (0-
14), adolescent (15-19) and young population (20-29 
years), for which we have converted the morphology 
and topography ICDO-3 codes [22] in the register to 
the 3° International Classification of Childhood Can-
cer (ICCC) classification [23]. The investigated cancer 
sites, includes all malignant cancers and 13 specific 
sites [14]. Excess cases have been evaluated with SIR. 
Expected cases between 2006 and 2010 have been cal-
culated from the national AIRTUM database, exclud-
ing individuals resident in a municipality belonging to 
a NPCS.
Each SIR was coupled with a 90% confidence interval 
(CI) from a Poisson regression model, if the number of 
cases was smaller than 100, and by Byar’s approxima-
tion when greater [24].
Congenital anomalies
CAs information has been selected from the popula-
tion-based registry of Milan, which includes cases with 
CAs among live births (up to 15 months of age), still-
birth (with gestational age ≥ 20 weeks) and TOPFA. 
CAs among termination of pregnancy have been col-
lected from hospital discharge records, including admis-
sions with codes for both termination of pregnancy and 
CAs. In order to identify the termination of pregnancy 
for foetus anomalies, for women with termination of 
pregnancy hospital discharge codes and genetic exams 
6 months prior admission, a record linkage to the patho-
logical anatomy has been performed. The population-
based registry of the province of Milan includes cases 
resident in the province of Milan from 2012 to 2014. We 
have investigated overall CAs and 12 CAs subgroups, as 
defined by EUROCAT [25] and classified by ICD10-
BPA codes [14, 26, 27]. Cases with multiple anomalies 
have been considered as a single case in the definition of 
total cases, while cases with only minor and unspecified 
anomalies [25] have been excluded. Results have been 
displayed as number of observed cases and prevalence 
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of CAs by municipality of residence of the mother. In 
order to compare residents with non-residents, we have 
calculated, for each of the CA’s subgroups, the preva-
lence ratio (PR) between the prevalence of CAs in the 
site of Sesto San Giovanni and that in the overall area 
covered by the registry. PRs were presented with the 
corresponding 90% confidence interval.
In line with SENTIERI approach, we used a 90% 
CI in order to reduce the critical use of the CI as a 
surrogate of the hypothesis test [27, 28]. All analyses 
have been performed using SAS Software (version 9.4, 
SAS Institute Inc., Cary, NC, USA). For identifiability 
concerns, cancer and congenital anomalies’ results will 
not be displayed for subgroups with a number of cases 
smaller than three.
RESULTS
In the site of Sesto San Giovanni, there have been 
5565 cases of cancer between 2007 and 2013 of which 
53% in men. We found an overall significant negative 
association with all cancers excluding skin, both for 
men and women with a SMR of 88 (90% CI 85-91) 
and 95 (90% CI 92-98), respectively (Table 1). For men, 
we found a statistically significant increased risk in the 
NPCS resident for bladder’s cancer (SMR 121; 90% 
CI 111-131), leukaemia (SMR 133; 90% CI 112-157), 
lymphoid leukaemia (SMR 135; 90% CI 102-175) and 
chronic lymphocytic leukaemia (SMR 152; 90% CI 
113-201). For women, we found a statistically signifi-
cant increased risk in the NPCS resident for lung (SMR 
114; 90% CI 101-128) and breast cancer (SMR 112; 
90% CI 106-118).
In the paediatric, adolescent and young population we 
observed 66 cases of cancer between 0 and 29 years of 
which 21 (32%) in the paediatric, 7 (11%) in the adoles-
cent and 38 (58%) in the young adult population (Table 
2). We found an overall, but not statistically significant, 
negative association with all malignant cancers, except 
for the age 0-14 were resident in the NPCS were at in-
creased risk (SMR 113; 90% CI 76-163). For the paedi-
atric and adolescent population, there was a statistically 
significant increased risk only for embryonic tumours 
with a SIR of 262 (90% CI 114-518) and 821 (90% CI 
408-1480) respectively. We did not find any increased 
statistically significant risk for the NPCS resident in the 
young-adult population. Results for lymphoid leukaemia 
and neuroblastoma are not displayed because the ob-
served cases were smaller than three for all ages.
The total number of CAs between 2012 and 2014 
in the NPCS was 86 out of 3529 births (according to 
the Italian National Institute of Statistics, ISTAT [29]) 
with a prevalence of 243.7 cases per 10 000 inhabitants 
(Table 3). In the province of Milan, the total number 
of cases were 1485 out of 56 029 births with a preva-
lence of 265.0 per 10 000 inhabitants. The prevalence 
ratio for total CAs was thus 92 (90% CI 83-102), show-
ing an observed number of events not different from 
the expected. We observed excess cases in the resident 
population for ear, face and neck defects (PR = 176; 
90% CI 106-274), digestive system (PR = 156; 90% CI 
115-203) and chromosomal defects (PR = 176; 90% CI 
133-222). Results for respiratory and abdominal wall 
Table 1
Number of observed cases (N), standardized incidence ratio 
(SIR*100), 90% confidence intervals (CI) for cancer site by gender.
Cancer sites
Men Women
N SIR (90% CI) N SIR (90% CI)
All cancers, 
excluding skin 
2947 88 (85-91) 2618 95 (92-98)
Esophagus 33 99 (72-132) 5 42 (17-89)
Stomach 145 90 (78-103) 99 92 (78-109)
Colorectal 428 97 (90-105) 303 84 (76-93)
Liver 148 90 (78-104) 45 62 (48-79)
Gallbladder 36 111 (82-147) 46 109 (84-139)
Pancreas 90 92 (77-110) 115 107 (91-125)
Larynx 62 98 (78-121) 4 48 (16-109)
Lung 552 107 (99-114) 212 114 (101-128)
Bone 7 129 (60-242) <3
Mesothelioma 18 71 (46-106) 18 146 (95-217)
Soft tissue sarcoma 24 136 (94-191) 19 127 (83-187)
Soft tissue 
sarcoma*
20 129 (85-187) 16 124 (78-189)
Melanoma of skin 64 74 (59-91) 47 56 (44-72)
Breast 9 113 (59-197) 947 112 (106-118)
Uterus 159 93 (81-106)
Cervix uteri 42 97 (74-126)
Corpus uteri 113 91 (77-107)
Ovary 88 100 (83-120)
Prostate 444 65 (60-71)
Testis 22 68 (46-97)
Kidney and urinary 
tract
121 90 (77-105) 57 79 (63-99)
Bladder 398 121 (111-131) 82 102 (84-122)
Brain and other 
parts of the central 
nervous system
47 101 (78-129) 38 97 (73-127)
Thyroid 26 84 (59-117) 68 76 (62-93)
Lymphoid, 
hematopoietic and 
related tissue
281 111 (100-122) 199 92 (82-104)
Hodgkin 
lymphoma
20 114 (75-165) 8 52 (26-93)
Non-Hodgkin 
lymphoma
109 94 (80-110) 88 85 (71-102)
Myeloma 48 110 (85-140) 47 115 (89-147)
Leukaemia 102 133 (112-157) 57 101 (80-126)
Lymphoid 
leukaemia
41 135 (102-175) 23 107 (73-152)
Acute 
lymphoblastic 
leukaemia
5 75 (30-157) <3
Chronic 
lymphocytic 
leukaemia
36 152 (113-201) 21 131 (88-189)
Myeloid leukaemia 39 123 (92-160) 22 92 (62-131)
Acute Myeloid 
leukaemia
26 124 (87-172) 15 87 (54-134)
Chronic Myeloid 
leukaemia
13 121 (71-192) 7 103 (48-194)
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defects are not shown because the observed number of 
cases was smaller than three.
DISCUSSION
The evaluation of the health profile of populations 
living closer to industrially contaminated areas is im-
portant in the public health framework. For NPCSs 
characterized by single and well-defined environmental 
exposures, tracing an impact on health can be straight-
forward. This attribution is complex when the con-
taminated site presents multiple and heterogeneous 
sources of contamination. In the previous editions of 
SENTIERI [12,14], residents in the site of Sesto San 
Giovanni did not have any statistically significant risk 
excesses for all-cause and for principal causes of mor-
tality for both men and women. A different pattern has 
been found on hospitalizations, were excess risks were 
found for all-cause and for respiratory diseases. Similar 
associations were found for the paediatric, adolescent 
and young adult’s population. 
The environmental sources characterizing the NPCS 
of Sesto San Giovanni, landfill and steel industry, were 
classified by SENTIERI as having a sufficient or limited 
level of evidence of association with respiratory diseases 
and asthma. Fazzo et al. [15] from a literature review, 
evaluated as limited the evidence of a causal associa-
tion between hazardous waste related exposures and 
liver, breast, testis and bladder cancers, non-Hodgkin 
lymphoma and asthma and finally overall and specific 
congenital anomalies. Here we found an overall nega-
tive association between living in the NPCS and overall 
cancer incidence for all ages, and a number of observed 
cases not different from the expected for the paediatric, 
adolescent and young adults’ population. On the other 
hand, we found an excess risk for bladder cancer in men 
and for breast cancer in women, cancers consistent with 
the environmental characteristic of the site. 
Table 3
Number of observed cases (N), prevalence ratio (PR*100), 90% 
confidence intervals (CI) for Congenital Anomalies, total and 
cause specific
Type of anomalies N PR (90% CI)
Nervous
system
10 136 (95-183)
Eye 4 151 (88-260)
Ear, face and neck 5 176 (106-274)
Congenital heart defects 39 84 (71-98)
Oro-facial clefts 4 84 (44-130)
Digestive system 13 156 (115-203)
Urinary system 5 51 (30-78)
Genital 11 116 (83-155)
Limb 12 102 (76-137)
Chromosomal 16 176 (133-222)
Total 86 92 (83-102)
Table 2
Number of observed paediatric, adolescent and young adults cases (N), standardized incidence ratio (SIR*100), 90% confidence 
intervals (CI) for cancer site
Age classes
0-14 years 15-19 years 0-19 years 20-29 years 0-29 years
Cancer sites N SIR (90% CI) N SIR (90% CI) N SIR (90% CI) N SIR (90% CI) N SIR (90% CI)
All malignant cancers 21 113 (76-163) 7 72 (34-136) 28 99 (71-136) 38 77 (58-101) 66 85 (69-104)
All malignant and non-
malignant SNC cancers
21 103 (69-149) 7 68 (32-128) 28 92 (65-125) 38 75 (56-98) 66 81 (65-100)
All haematological 
tumours 
9 99 (52-173) 4 92 (32-211) 13 97 (57-154) 10 81 (44-138) 23 89 (61-127)
Leukaemia 5 79 (31-166) < 3 6 80 (35-157) <3 7 67 (31-126)
Acute myeloid leukaemia 3 292 (80-755) < 3 3 225 (61-581) <3 3 140 (38-362)
Lymphomas 4 146 (50-333) 3 96 (26-247) 7 119 (56-224) 9 96 (50-168) 16 105 (66-159)
Hodgkin lymphomas < 3 < 3 3 88 (24-228) 6 99 (43-196) 9 95 (50-166)
Non-Hodgkin lymphomas 3 223 (61-577) < 3 4 193 (66-442) 3 103 (28-267) 7 141 (66-264)
Central nervous system 
tumours- malignant
< 3 < 3 < 3 <3 4 81 (28-185)
Central nervous system 
tumours- malignant and 
non-malignant
< 3 < 3 < 3 <3 4 46 (16-105)
Soft tissue and other extra 
osseous sarcomas
< 3 < 3 < 3 4 229 (78-525) 4 121 (41-277)
Germ cell tumours, 
trophoblastic tumours, 
and neoplasms of gonads
< 3 < 3 3 211 (58-545)
Thyroid carcinomas < 3 < 3 5 59 (23-123) 5 49 (19-104)
Embryonic tumours 6 262 (114-518) < 3 8 821 (408-1480)
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In order to define the overall health profile of the pop-
ulation living in the site of Sesto San Giovanni, we pre-
sented SIRs for all the causes investigated. We found risk 
excess for Leukaemia, Lymphoid leukaemia and chronic 
lymphocytic leukaemia in the adult’s population. Even if 
they are not directly referable to the environmental char-
acteristic of the site, these causes are defined by SEN-
TIERI as inadequate to infer the presence but also the 
absence of a causal association. Furthermore, we found 
a significant association between living in the NPCS and 
lung cancer in women. Nevertheless, lung cancer inci-
dence has a significant increasing trend in women since 
early two thousands at national and international level, 
more consistent in urban areas and due to the increase 
in smoking habits in women. Not having found an asso-
ciation in the male gender further supports this consid-
eration. Negative associations in adults were found for 
melanoma of skin for both genders, prostate and testis 
for men and kidney and urinary tract, thyroid and Hodg-
kin lymphoma for women. For the young adults’ popula-
tion, negative associations were found for all malignant 
and non-malignant CNS cancers. Total CAs were not 
different from expected in Sesto San Giovanni’s resi-
dents, while we found excesses for ear, face and neck 
defects, digestive system and chromosomal defects. 
Negative associations were found for congenital 
heart defects and urinary system. It is important to re-
member that the identification of Sesto San Giovanni 
as a National contaminated site goes back to 2010 and 
it referred to a steel industry that closed in 1996. Fur-
thermore, these results showed a plausible effect of air 
pollution, which is a well-known problem of the mu-
nicipalities, such as Sesto San Giovanni, localized in the 
north of the Milan province. In particular, the possible 
correlation between ambient air pollution and orofacial 
cleft anomalies in new-borns was recently reported in 
a systematic review and meta-analysis but only ozone 
showed the strongest correlation with cleft lip and cleft 
palate anomalies [30]. 
Comparing NPCSs is difficult given the different 
sources that characterized each site. In the NPCS of 
Terni-Papigno, which share the same sources of expo-
sure with Sesto San Giovanni, the SENTIERI project 
found an association with lung cancer in both men and 
women, with breast cancer in women and with non-
Hodgkin lymphoma in men. Breugelmans et al. [18] 
found that the SIR for lung cancer was 40% higher than 
average in postcode areas closer to industrial terrain of 
a steel plant.
As all ecological studies based on routinely collected 
data, this procedure presents some biases. First, data 
quality is taken for granted. Here, we used data from 
the Cancer Registry of the ATS of Milan and from the 
CAs Registry accredited and validated from IARC and 
EUROCAT respectively. Furthermore, when read-
ing these results, we have to be aware that exposure is 
defined from municipality where aggregated data can 
suffer from the ecological fallacy, especially in relatively 
small populations where limited number of cases per 
cancer sites may affect statistical power. However, the 
selection of diseases on the basis of a priori evidence 
should limit the typical biases of descriptive studies in-
volving data dredging and multiple testing [5]. 
CONCLUSIONS
Assessing the health impact of NPCSs on residents 
is a fundamental priority of public health organizations, 
as previous and existing environmental stressors can 
cause local and diffuse accumulation of adverse health 
conditions. Once the risk has been assessed, the next 
challenge is to implement policies capable to respond 
to this need, especially analysing the associations be-
tween specific environmental exposures and the health 
outcomes detected. Public health organizations are 
even more challenged on environmental issues as the 
demand for participation has increased, transforming 
ordinary concerns in public requests where citizen play 
the role of principal actors.
This work adds necessary information on the health 
profile of a population defined as susceptible by nation-
al regulations. When new information are available for 
Public health organizations, at delayed times in respect 
to the release of scientific evidence, it is necessary to 
communicate them in order to complete and integrate 
the knowledge, especially when it comes from environ-
mental issues.
Acknowledgment
The authors thank the SENTIERI working group and 
its scientific director Amerigo Zona for the collabora-
tion. 
Conflict of interest statement
There are no potential conflicts of interest or any fi-
nancial or personal relationships with other people or 
organizations that could inappropriately bias conduct 
and findings of this study.
Received on 8 March 2019.
Accepted on 24 July 2019.
REFERENCES
1. World Health Organization. Contaminated sites and 
health. Report of two WHO workshops: Syracuse, Italy, 
18 November 2011, Catania, Italy, 21-22 June 2012. Co-
penhagen, Denmark: WHO Regional Office for Europe; 
2013.
2. Mudu P, Terracini B, Martuzzi M. Human Health in Ar-
eas with Industrial Contamination. Copenhagen, Den-
mark: WHO Regional Office for Europe; 2014.
3. van Liedekerke M, Prokop G, Rabl-Berger S, Kibblewhite 
M, Louwagie G. Progress in the managment of Contami-
nated Sites in Europe. Eur Comm Jt Res Cent. 2014.
4. Istituto Superiore per la Protezione e la Ricerca Ambien-
tale. Contaminated sites. ISPRA; 2018. Available from: 
www.isprambiente.gov.it/en/topics/soil-and-territory/
copy_of_contaminated-sites?set_language=en.
5. Pasetto R, Martin-Olmedo P, Martuzzi M, Iavarone I. 
Rossella Murtas, Anita Andreano, Maria Teresa Greco et al.
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
350
Exploring available options in characterising the health 
impact of industrially contaminated sites. Ann Ist Super 
Sanità. 2016;52:476-82. doi:10.4415/ANN_16_04_03
6. Pascal L, Pascal M, Stempfelet M, Goria S, Declercq C. 
Ecological study on hospitalizations for cancer, cardio-
vascular, and respiratory diseases in the industrial area of 
Etang-de-Berre in the South of France. J Environ Public 
Health. 2013;2013. doi:10.1155/2013/328737
7. Palmer SR, Dunstan FDJ, Fielder H, Fone DL, Higgs 
G, Senior ML. Risk of congenital anomalies after the 
opening of landfill sites. Environ Health Perspect. 
2005;113:1362-5. doi:10.1289/ehp.7487.
8. Jarup L, Briggs D, de Hoogh C, Morris S, Hurt C, Lewin 
A, et al. Cancer risks in populations living near land-
fill sites in Great Britain. Br J Cancer. 2002;86:1732-6. 
doi:10.1038/sj.bjc.6600311
9. Bauleo L, Bucci S, Antonucci C, Sozzi R, Davoli M, 
Forastiere F, et al. Long-term exposure to air pollutants 
from multiple sources and mortality in an industrial area: 
a cohort study. Occup Environ Med. 2019;76:48-57. 
doi:10.1136/oemed-2018-105059
10. Snoj Tratnik J, Falnoga I, Mazej D, Kocman D, Fajon 
V, Jagodic M, et al. Results of the first national human 
biomonitoring in Slovenia: Trace elements in men and 
lactating women, predictors of exposure and reference 
values. Int J Hyg Environ Health. 2019;222:563-82. 
doi:10.1016/j.ijheh.2019.02.008
11. Pirastu R, Ancona C, Iavarone I, Mitis F, Zona A, Comba 
P, et al. SENTIERI Project. Mortality, cancer incidence 
and hospital discharges. Epidemiol Prev. 2010;34:1-2.
12. Pirastu R, Iavarone I, Pasetto R, Zona A, Comba P, SEN-
TIERI Working Group. SENTIERI Project. Mortality 
study of residents in Italian polluted sites: results. Epide-
miol Prev. 2011;35:1-2.
13. Pirastu R, Comba P, Conti S, Iavarone I, Fazzo L, Paset-
to R, et al. SENTIERI – Epidemiological study of resi-
dents in national priority contaminated sites: Mortality 
study of residents in Italian polluted sites: results. Epide-
miol Prev. 2014;38.
14. Zona A, Pasetto R, Fazzo L, Iavarone I, Bruno C, Pirastu 
R, et al. SENTIERI – Studio epidemiologico nazionale dei 
territori e degli insediamenti esposti a rischio da Inquina-
mento: Quinto rapporto. Epidemiol Prev. 2019;43(2-3).
15. Fazzo L, Minichilli F, Santoro M, Ceccarini A, Della Seta 
M, Bianchi F, et al. Hazardous waste and health impact: 
a systematic review of the scientific literature. Environ 
Health. 2017;16. doi:10.1186/s12940-017-0311-8
16. Mattiello A, Chiodini P, Bianco E, Forgione N, Flammia 
I, Gallo C, et al. Health effects associated with the dis-
posal of solid waste in landfills and incinerators in popula-
tions living in surrounding areas: a systematic review. Int 
J Public Health. 2013;58:725-35. doi:10.1007/s00038-
013-0496-8
17. Kihal-Talantikite W, Zmirou-Navier D, Padilla C, Deguen 
S. Systematic literature review of reproductive outcome 
associated with residential proximity to polluted sites. Int 
J Health Geogr. 2017;16:20. doi:10.1186/s12942-017-
0091-y
18. Breugelmans O, Ameling C, Marra M, Fischer P, van de 
Kassteele J, Lijzen J, et al. Lung Cancer Risk and Past Ex-
posure to Emissions from a Large Steel Plant. J Environ 
Public Health. 2013. doi:10.1155/2013/684035
19. Bhopal R, Tate J, Foy C, Moffatt S, Phillimore P. Resi-
dential proximity to industry and adverse birth out-
comes. The Lancet. 1999;354:920-1. doi:10.1016/S0140-
6736(99)01687-6
20. World Health Organization. ICD-10: International sta-
tistical classification of diseases and related health prob-
lems. Geneva: WHO; 2011.
21. Associazione Italiana Registri Tumori. Sito dell’AIRTUM. 
Available from: www.registri-tumori.it/cms/.
22. World Health Organization. International classification 
of diseases for oncology. 3rd Edition (ICD-O-3). WHO; 
2000. Available from: www.who.int/classifications/icd/ad-
aptations/oncology/en/.
23. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. In-
ternational classification of childhood cancer, third edi-
tion. Cancer. 2005;103:1457-67. doi:10.1002/cncr.20910
24. Breslow NE, Day NE. Statistical methods in cancer re-
search. Volume 2 – The design and analysis of cohort 
studies. IARC Sci Publ. 1987:1-406.
25. EUROCAT Guide 1.4 and Reference Documents 2013. 
Available from: www.eurocat-network.eu/content/EU-
ROCAT-Guide-1.4-Full-Guide.pdf.
26. Crawshaw P. The new BPA classification. Arch Dis Child. 
1995;73:563-7. doi:10.1136/adc.73.6.563
27. Santoro M, Minichilli F, Pierini A, Astolfi G, Bisceglia L, 
Carbone P, et al. Congenital Anomalies in contaminated 
sites: A multisite study in Italy. Int J Environ Res Public 
Health. 2017;14. doi:10.3390/ijerph14030292
28. Sterne JAC, Smith GD. Sifting the evidence – what’s 
wrong with significance tests? BMJ. 2001;322:226-31.
29. Istituto Nazionale di Statistica. Demo-Geodemo. Mappe, 
popolazione, statistiche demografiche dell’ISTAT. ISTAT. 
Available from: http://demo.istat.it/. 
30. Rao A, Ahmed MK, Taub PJ, Mamoun JS. The corre-
lation between maternal exposure to air pollution and 
the risk of orofacial clefts in infants: a systematic re-
view and meta-analysis. J Oral Maxillofac Res. 2016;7. 
doi:10.5037/jomr.2016.7102
